Tag: cancer

ATLANTA -- The investigational therapeutic umbralisib, which targets the molecule PI3K-delta, was well tolerated and highly active in patients with ...

Data from two KEYNOTE trials show pembrolizumab benefited patients with advanced SCLC

ATLANTA -- The anti-PD-1 monoclonal antibody pembrolizumab (Keytruda) showed promising antitumor activity with durable responses in patients with pretreated, advanced ...

Targeted drug for leukemia tested at Penn Medicine helps patients live longer

Data presented at AACR Annual Meeting on recently approved drug that targets common mutation in AML ATLANTA - An inhibitor ...

Single agent umbralisib effective for relapsed slow-growing lymphoma

MD Anderson Phase II trial shows drug well tolerated with high response rates for marginal zone lymphomaCredit: MD Anderson Cancer ...

Biopsy alternative: ‘Wearable’ device captures cancer cells from blood

Credit: Tae Hyun Kim ANN ARBOR, Michigan -- A prototype wearable device, tested in animal models, can continuously collect live ...

New evidence about why clear margins in breast cancer surgery are such good news

Credit: Phil Jones, Senior Photographer, Augusta University AUGUSTA, Ga. (April 1, 2019) - When a breast cancer tumor is removed ...

New glioblastoma vaccine shows promising results in phase Ib clinical trial

A brain-cancer vaccine more than 20 years in the making suspends cancer growth in patients enrolled in early-stage trial. (PHILADELPHIA) ...

CD40 combination therapy can shrink pancreatic tumors

Study results to be presented during a plenary session at AACR Annual Meeting ATLANTA - A new combination of immunotherapy ...

Excess body weight before 50 is associated with higher risk of dying from pancreatic cancer

ATLANTA --Excess weight before age 50 may be more strongly associated with pancreatic cancer mortality risk than excess weight at ...

Pancreatic Cancer Collective funds two AI teams to identify high-risk populations

Computational tools seek to identify pancreatic cancer earlier, provide more opportunities for timely, effective treatmentsCredit: Pancreatic Cancer Collective (ATLANTA - ...

Immunotherapy combination effective for patients with rare neuroendocrine cancer

Credit: Hope Foundation for Cancer Research A combination of two common immunotherapy drugs shrinks rare, aggressive neuroendocrine tumors, according to ...

Adding savolitinib to osimertinib beneficial for certain pretreated lung cancer patients

ATLANTA -- Adding the investigational MET inhibitor savolitinib to the EGFR inhibitor osimertinib (Tagrisso) yielded clinical responses in patients who ...

Immune checkpoint inhibitor combo efficacious for patients with neuroendocrine carcinoma

ATLANTA -- A combination of the anti-CTLA-4 immunotherapeutic ipilimumab (Yervoy) and the anti-PD-1 immunotherapeutic nivolumab (Opdivo) showed clinical benefit among ...

HER2-targeted CAR T-cell therapy shows promising antitumor activity in patients with sarcoma